BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Radiopharmaceuticals
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, September 22, 2023
Home » Topics » Regulatory » Patents

Patents
Patents RSS Feed RSS

Searle claims NOS inhibitors

July 5, 1996
No Comments

BMS describes antifungal effects of ascosteroside

July 5, 1996
No Comments

Lilly's 5-HT1F agonists for migraine

July 5, 1996
No Comments

Merck & Co. reveals growth hormone release promoters

June 28, 1996
No Comments

5-HT4 agonists in Nisshin Flour Milling's pipeline

June 28, 1996
No Comments

Human Genome Sciences discloses polypeptide research

June 28, 1996
No Comments

Fibrinogen antagonists in Terumo's pipeline

June 28, 1996
No Comments

Nippon Mining reports on HV1C3

June 28, 1996
No Comments

SmithKline Beecham antiarrhythmic research revealed

June 28, 1996
No Comments

Phospholipase A2 inhibitors for atherosclerosis treatment

June 28, 1996
No Comments
Previous 1 2 … 3420 3421 3422 3423 3424 3425 3426 3427 3428 … 3462 3463 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Sept. 21, 2023.
  • Myelin sheath and neurons in the brain

    Myelin damaged by multiple sclerosis could be repaired by reducing levels of an enzyme

    BioWorld Science
    In multiple sclerosis (MS), macrophages and microglia play a dual role that could be used to treat this neurodegenerative disease. These cells promote...
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for September 21, 2023.
  • Hands holding torn contract

    Quite a fix: Orthofix sacks three top execs

    BioWorld MedTech
    Orthofix Medical Inc. terminated its CEO, chief financial officer and chief legal officer in a move that plunged the stock from $18.63 at Monday’s close to $13.01...
  • Financial chart and flag of China

    Challenges in China spell trouble for Illumina, 10x and others

    BioWorld MedTech

    China’s recovery from its zero-COVID policy has failed to gain the momentum expected, with many experts predicting a slow or even negative growth rate. A slower...

BioFuture ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing